AMC ENTERTAINMENT HOLDINGS, INC. (AMC)
SIC breadcrumb: Services > Motion Pictures > SIC 7830 Services-Motion Picture Theaters
SEC company page: https://www.sec.gov/edgar/browse/?CIK=1411579. Latest filing source: 0001411579-26-000016.
Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.
At a glance
- Revenue
- 4,848,900,000 USD verified
- Net income
- -632,400,000 USD verified
- Assets
- 8,017,800,000 USD verified
- Free cash flow
- -365,900,000 USD computed
- Net margin
- -13.04% computed
- Operating margin
- -0.36% computed
- Revenue YoY
- +4.57% computed
Peer & cluster context
Peer percentile fingerprint
Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 78 Motion Pictures, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.
Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
|---|---|---|---|---|
| Revenue | 4,848,900,000 | USD | 2025 | 2026-02-23 |
| Net income | -632,400,000 | USD | 2025 | 2026-02-23 |
| Assets | 8,017,800,000 | USD | 2025 | 2026-02-23 |
Financials
Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-23. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001411579.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,235,900,000 | 5,079,200,000 | 5,460,800,000 | 5,471,000,000 | 1,242,400,000 | 2,527,900,000 | 3,911,400,000 | 4,812,600,000 | 4,637,200,000 | 4,848,900,000 |
| Net income | 111,700,000 | -487,200,000 | 110,100,000 | -149,100,000 | -4,589,100,000 | -1,269,100,000 | -973,600,000 | -396,600,000 | -352,600,000 | -632,400,000 |
| Operating income | 213,600,000 | 102,000,000 | 265,000,000 | 136,000,000 | -4,102,700,000 | -930,000,000 | -522,300,000 | -74,300,000 | -79,300,000 | -17,400,000 |
| Diluted EPS | 1.13 | -3.80 | 0.41 | -1.44 | -19.58 | -13.29 | -9.29 | -2.37 | -1.06 | -1.34 |
| Operating cash flow | 431,700,000 | 537,400,000 | 523,200,000 | 579,000,000 | -1,129,500,000 | -614,100,000 | -628,500,000 | -215,200,000 | -50,800,000 | -119,800,000 |
| Capital expenditures | 421,700,000 | 626,800,000 | 576,300,000 | 518,100,000 | 173,800,000 | 92,400,000 | 202,000,000 | 225,600,000 | 245,500,000 | 246,100,000 |
| Assets | 8,641,800,000 | 9,805,900,000 | 9,495,800,000 | 13,675,800,000 | 10,276,400,000 | 10,821,500,000 | 9,135,600,000 | 9,009,200,000 | 8,247,500,000 | 8,017,800,000 |
| Liabilities | 6,631,100,000 | 7,692,700,000 | 8,097,800,000 | 12,461,600,000 | 13,134,600,000 | 12,611,000,000 | 11,760,100,000 | 10,857,100,000 | 10,008,000,000 | 9,912,600,000 |
| Stockholders' equity | 2,009,600,000 | 2,112,400,000 | 1,397,600,000 | 1,214,200,000 | -2,885,100,000 | -1,789,500,000 | -2,624,500,000 | -1,847,900,000 | -1,760,500,000 | -1,894,800,000 |
| Cash and cash equivalents | 207,100,000 | 310,000,000 | 313,300,000 | 265,000,000 | 308,300,000 | 1,592,500,000 | 631,500,000 | 884,300,000 | 632,300,000 | 428,500,000 |
| Free cash flow | 10,000,000 | -89,400,000 | -53,100,000 | 60,900,000 | -1,303,300,000 | -706,500,000 | -830,500,000 | -440,800,000 | -296,300,000 | -365,900,000 |
Ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 3.45% | -9.59% | 2.02% | -2.73% | -50.20% | -24.89% | -8.24% | -7.60% | -13.04% | |
| Operating margin | 6.60% | 2.01% | 4.85% | 2.49% | -36.79% | -13.35% | -1.54% | -1.71% | -0.36% | |
| Return on assets | 1.29% | -4.97% | 1.16% | -1.09% | -44.66% | -11.73% | -10.66% | -4.40% | -4.28% | -7.89% |
| Current ratio | 0.57 | 0.62 | 0.59 | 0.35 | 0.31 | 1.05 | 0.53 | 0.74 | 0.54 | 0.41 |
Industry Peer Context
Net margin peer context
Financial Bridges
Free cash flow = operating cash flow - capital expenditures
Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001411579-26-000016; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001411579-26-000016; concept PaymentsToAcquireProductiveAssets; source concepts us-gaap:PaymentsToAcquireProductiveAssets | Free cash flow: accession 0001411579-26-000016; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquireProductiveAssets; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquireProductiveAssets
Financial Charts
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: Revenues. Source concepts: us-gaap:Revenues.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: PaymentsToAcquireProductiveAssets. Source concepts: us-gaap:PaymentsToAcquireProductiveAssets.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: Assets. Source concepts: us-gaap:Assets.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: Liabilities. Source concepts: us-gaap:Liabilities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001411579-26-000016; filed 2026-02-23. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquireProductiveAssets. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquireProductiveAssets.
As-reported value updates
Quarterly
Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-07-23. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001411579.json.
| Quarter | End Date | Revenue | Net Income | Diluted EPS | Method |
|---|---|---|---|---|---|
| 2022-Q3 | 2022-09-30 | -0.22 | reported discrete quarter | ||
| 2023-Q1 | 2023-03-31 | -0.17 | reported discrete quarter | ||
| 2023-Q2 | 2023-06-30 | 0.01 | reported discrete quarter | ||
| 2023-Q3 | 2023-06-30 | 8,600,000 | reported discrete quarter | ||
| 2023-Q3 | 2023-09-30 | 1,405,900,000 | 0.08 | reported discrete quarter | |
| 2023-Q4 | 2023-12-31 | 1,104,400,000 | -182,000,000 | derived Q4 = FY annual - nine-month YTD | |
| 2024-Q1 | 2024-03-31 | 951,400,000 | -163,500,000 | -0.62 | reported discrete quarter |
| 2024-Q2 | 2024-03-31 | -163,500,000 | reported discrete quarter | ||
| 2024-Q2 | 2024-06-30 | 1,030,600,000 | -0.10 | reported discrete quarter | |
| 2024-Q3 | 2024-06-30 | -32,800,000 | reported discrete quarter | ||
| 2024-Q3 | 2024-09-30 | 1,348,800,000 | -0.06 | reported discrete quarter | |
| 2024-Q4 | 2024-12-31 | 1,306,400,000 | -135,600,000 | derived Q4 = FY annual - nine-month YTD | |
| 2025-Q1 | 2025-03-31 | 862,500,000 | -202,100,000 | -0.47 | reported discrete quarter |
| 2025-Q2 | 2025-03-31 | -202,100,000 | reported discrete quarter | ||
| 2025-Q2 | 2025-06-30 | 1,397,900,000 | -0.01 | reported discrete quarter | |
| 2025-Q3 | 2025-06-30 | -4,700,000 | reported discrete quarter | ||
| 2025-Q3 | 2025-09-30 | 1,300,200,000 | -0.58 | reported discrete quarter | |
| 2025-Q4 | 2025-12-31 | 1,288,300,000 | -127,400,000 | derived Q4 = FY annual - nine-month YTD | |
| 2026-Q1 | 2026-03-31 | 1,045,400,000 | -117,100,000 | -0.22 | reported discrete quarter |
| 2026-Q2 | 2026-03-31 | -117,100,000 | reported discrete quarter | ||
| 2026-Q2 | 2026-06-30 | 1,596,700,000 | -0.02 | reported discrete quarter |
Quarterly Charts
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001411579-26-000059; filed 2026-07-23. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001411579-26-000051; filed 2026-05-05. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001411579-26-000059; filed 2026-07-23. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Business
Read AMC's verbatim Item 1 Business section from its latest 10-K: Business.
Risk Factors
Read AMC's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.
Latest quarter (10-Q)
Latest 10-Q source: 0001411579-26-000059.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Forward-Looking Statements
In addition to historical information, this Quarterly Report on Form 10–Q contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “may,” “will,” “forecast,” “estimate,” “project,” “intend,” “plan,” “expect,” “should,” “believe” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions and speak only as of the date on which it is made. Examples of forward-looking statements include statements we make regarding future attendance levels, revenues and our liquidity. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including those discussed in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the following:
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the risks and uncertainties relating to the sufficiency of our existing cash and cash equivalents and available borrowing capacity to fund operations and satisfy obligations including cash outflows for planned capital expenditures currently and through the next twelve months. Based on our current cost structure, in order to achieve annual net positive cash flows from operating activities, revenues will need to be at least in line with pre-COVID-19 revenues. However, there remain significant risks that may negatively impact revenues, costs, and attendance levels, including changes to movie studios release schedules (including as a result of production delays and delays to the release of movies caused by labor stoppages) and direct to streaming or other changing movie studio practices. If we are unable to achieve increased levels of attendance and revenues, we will be required to obtain additional liquidity. If such additional liquidity is not obtained or is insufficient, we likely would seek an in-court or out-of-court restructuring of our liabilities, and in the event of such future liquidation or bankruptcy proceeding, holders of our Common Stock and other securities would likely suffer a total loss of their investment; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the risks and uncertainties relating to the 2025 Refinancing Transactions and 2024 Refinancing Transactions (each defined herein), including, but not limited to, (i) the potential for additional future dilution of our Common Stock as a result of issuance of shares underlying our Existing Exchangeable Notes, (ii) the possibility that the extension of certain debt maturities will not provide enough time for attendance and revenues to increase to sufficient levels and generate net positive cash flows to overcome liquidity concerns, and (iii) the impact on the market price of our Common Stock and our capital structure |
31
Table of Contents
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| of any litigation or claims of default that might arise in connection with the 2025 Refinancing Transactions or 2024 Refinancing Transactions; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | changing practices of distributors, which accelerated during the COVID-19 pandemic, including increased use of alternative film delivery methods including premium video on demand, streaming platforms, shrinking exclusive theatrical release windows or release of movies to theatrical exhibition and streaming platforms on the same date, the theatrical release of fewer movies due to industry consolidation or other reasons, or transitioning to other forms of entertainment; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the impact of changing movie-going behavior of consumers; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the risk that the North American and international box office in the near term will not recover sufficiently, resulting in continued cash burn and the need to seek additional financing, which may not be available at favorable terms, or at all; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | risks and uncertainties relating to our significant indebtedness, including our borrowings and our ability to meet our debt covenants; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the dilution caused by recent and potential future sales of our Common Stock and future potential share issuances to repay, refinance, redeem or repurchase indebtedness (including expenses, accrued interest and premium, if any); |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | risks relating to motion picture production, promotion, marketing, and performance, including labor stoppages affecting the production, supply and release schedule of theatrical motion picture content and choice of distributors to release fewer feature-length films as a result of the additional financial burden imposed by tariffs on motion picture production; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the potential impact on our business resulting from consolidation among, or structural changes to, movie studios, distribution companies, or producers of other third-party media, including the uncertainty created when any such transaction is the subject of pending regulatory review, judicial proceedings, or injunctive relief, the outcome of which may materially affect the structure and dynamics of the markets in which we operate and the production and release of theatrical motion pictures; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the use of artificial intelligence (“AI”) technology in the filmmaking process and audience acceptance of movies made utilizing AI technology; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the seasonality of our revenue and working capital, which are dependent upon the timing of motion picture releases by distributors, such releases being seasonal and resulting in higher attendance and revenues generally during the summer months and holiday seasons, and higher working capital requirements during the other periods such as the first quarter; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | intense competition in the geographic areas in which we operate among exhibitors, streaming platforms, or from other forms of entertainment; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | certain covenants in the agreements that govern our indebtedness that limit or restrict our ability to take advantage of certain business opportunities, pay dividends, incur additional debt, pre-pay debt, and also to refinance debt and to do so at favorable terms, and such covenants that impose additional administrative and operational burdens on our business; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | risks relating to impairment losses, including with respect to goodwill and other intangibles, and theatre and other closure charges; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | general and international economic, political, regulatory, social and financial market conditions, including potential economic recession, inflation, rising interest rates, the financial stability of the banking industry, and other risks that may negatively impact discretionary income and our revenues and attendance levels; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our lack of control over distributors of films; |
32
Table of Contents
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | limitations on the availability of capital or poor financial results may prevent us from deploying strategic initiatives; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | an issuance of preferred stock could dilute the voting power of the common stockholders and adversely affect the market value of our outstanding Common Stock; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | limitations on the authorized number of Common Stock shares could in the future prevent us from raising additional capital through sales of Common Stock; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our ability to achieve expected synergies, benefits and performance from our strategic initiatives; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our ability to refinance our indebtedness on terms favorable to us or at all; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our ability to optimize our theatre circuit through new construction, the transformation of our existing theatres, and strategically closing underperforming theatres may be subject to delay and unanticipated costs; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | failures, unavailability or security breaches of our information systems, including due to cybersecurity incidents; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our ability to utilize interest expense deductions will be limited annually due to Section 163(j) of the Internal Revenue Code of 1986, as amended, as amended by the One Big Beautiful Bill Act of 2025; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our ability to recognize interest deduction carryforwards, net operating loss carryforwards and other tax attributes to reduce our future tax liability; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | our ability to recognize certain international deferred tax assets which currently do not have a valuation allowance recorded; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | review by antitrust authorities in connection with acquisition opportunities; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | risks relating to the incurrence of legal liability; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | dependence on key personnel for current and future performance and our ability to attract and retain senior executives and other key personnel, including in connection with any future acquisitions; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | increased costs in order to comply or resulting from a failure to comply with governmental regulation, including the General Data Protection Regulation and all other current and pending privacy and data regulations in the jurisdictions where we have operations; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | supply chain disruptions may negatively impact our operating results; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the availability and/or cost of energy; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the market price and trading volume of our shares of Common Stock has been and may continue to be volatile, and purchasers of our securities could incur substantial losses; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | future offerings of debt, which would be senior to our Common Stock for purposes of distributions or upon liquidation, could adversely affect the market price of our Common Stock; |
| Column 1 | Column 2 | Column 3 |
|---|---|---|
| ● | the potential for political, social, or economic unrest, terrorism, hostilities, cyber-attacks or war, including the conflict between Russia and Ukraine, military actions in and around Iran, and other international conflicts; |
[[GREPCENT_TA
[Excerpt truncated for page length; source filing is linked above.]
Latest 10-K MD&A (excerpt)
Latest 10-K Item 7 source: 0001411579-26-000016. The complete FY 2025 MD&A is published at /company/AMC/mda/fy2025/.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion relates to the consolidated audited financial statements of AMC included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements. Please see “Forward-Looking Statements” and “Risk Factors” in Part I on this Annual Report on Form 10-K for a discussion of the risks, uncertainties and assumptions relating to these statements. See Note 1—The Company and Significant Accounting Policies in Notes to the Consolidated Financial Statements under Part II, Item 8 of this Form 10-K for information regarding the Company’s significant accounting policies.
Overview
AMC is the world’s largest theatrical exhibition company and an industry leader in innovation and operational excellence. As of December 31, 2025 we operated in 11 countries including the United States and throughout Europe.
Our theatrical exhibition revenues are generated primarily from box office admissions and food and beverage sales. The balance of our revenues is generated from ancillary sources, including online ticketing fees, on-screen advertising, income from gift card and exchange ticket sales, rental of theatre auditoriums, retail popcorn and merchandise sales, fees earned from our customer loyalty programs, and theatrical distribution. As of December 31, 2025, we owned, operated or had interests in 855 theatres and 9,640 screens.
Significant Events—For the Year Ended December 31, 2025
2025 Debt Refinancing and Additional Share Authorization. During the year ended December 31, 2025, we completed a series of refinancing transactions with certain holders of our Existing 7.5% Notes, certain holders of the Existing Exchangeable Notes, and certain lenders of our term loans outstanding under our credit agreement. Additionally, at the 2025 Annual Meeting of Stockholders held on December 10, 2025, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to increase the total number of authorized shares of the Company’s Common Stock from 550,000,000 to 1,100,000,000 shares of Common Stock. The increase in authorized shares allows for, among other things, the potential conversion of the Company’s New Exchangeable Notes that were issued as part of the refinancing transactions. See Note 7—Corporate Borrowings and Finance Lease Liabilities in the Notes to the Consolidated Financial Statements under Part II, Item 8 of this Form 10-K for further information regarding these transactions.
NCM ESA Amendment. On April 17, 2025, NCM (as defined herein) entered into the Amended ESA (as defined herein) with the Company. The term of the Amended ESA has been extended by five years through February 13, 2042. We treated the Amended ESA as a contract modification pursuant to ASC 606 – Revenue from Contracts with Customers. Accordingly, we have allocated the additional consideration received from the contract modification to the exhibitor services agreement contract liability and updated the discount rate used to account for the significant financing component to 16.12%. Prior to the contract modification, the weighted average discount rate used to account for the significant financing component was approximately 7.5%. The contract liability will be reclassified to other theatre revenue over the new term of the Amended ESA as the remaining performance obligations are satisfied. Concurrently with entering into the Amended ESA, NCM and the Company reached an agreement to, among other things, dismiss with prejudice the ongoing litigation between the parties.
43
Table of Contents
Shares Issuances. During the year ended December 31, 2025, we were paid $108.7 million as initial gross cash proceeds associated with the establishment of forward positions for 30.0 million shares of Common Stock.
Additionally, during the year ended December 31, 2025, we issued shares of Common Stock through an “at-the-market” offering. The below table summarizes the activity of the “at-the-market offering”:
| | | | |
|---|---|---|---|
| (In millions) | | December 31, 2025 | |
| Shares issued through at-the-market offering | | | 17.1 |
| At-the-market offering gross proceeds | | $ | 63.0 |
| Sales agent fees paid | | $ | 0.6 |
| Other third-party issuance costs incurred | | $ | 0.3 |
| Other third-party issuance costs paid | | $ | 1.5 |
See Note 8—Stockholders’ Deficit in the Notes to the Consolidated Financial Statements under Part II, Item 8 of this Form 10-K for further information on the share issuances.
Significant Events—For the Year Ended December 31, 2024
Debt Repurchases and Exchanges. The table below summarizes the various cash debt repurchase transactions, debt for equity exchange transactions, and cash and debt for equity exchange transactions that occurred during the year ended December 31, 2024. The debt for equity transactions were treated as early extinguishments of debt. In accordance with ASC 470-50-40-3, the reacquisition price of the extinguished debt was determined to be the fair value of the Common Stock exchanged. See Note 7—Corporate Borrowings and Finance Lease Liabilities in the Notes to the Consolidated Financial Statements under Part II, Item 8 of this Form 10-K for further information on these transactions.
| | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | Shares of | | | | | | | | | | |
| | | Aggregate Principal | | Common Stock | | Reacquisition | | (Gain)/Loss on | | Accrued Interest | |||||
| (In millions) | | Repurchased/Exchanged | | Exchanged | | Cost | | Extinguishment | | Paid/Exchanged | |||||
| Cash debt repurchase transactions: | | | | | | | | | | | | | | | |
| 5.75% Senior Subordinated Notes due 2025 | | $ | 8.9 | | | — | | $ | 8.6 | | $ | (0.3) | | $ | 0.1 |
| Second Lien Notes due 2026 | | | 50.0 | | | — | | | 50.5 | | | (4.4) | | | 1.4 |
| Total cash debt repurchase transactions | | | 58.9 | | | — | | | 59.1 | | | (4.7) | | | 1.5 |
| Debt for equity exchange transactions: | | | | | | | | | | | | | | | |
| 5.75% Senior Subordinated Notes due 2025 | | | 36.7 | | | 9,017,297 | | | 39.8 | | | 3.2 | | | 0.8 |
| Second Lien Notes due 2026 | | | 224.1 | | | 35,062,835 | | | 157.2 | | | (93.1) | | | 8.3 |
| Total debt for equity exchange transactions | | | 260.8 | | | 44,080,132 | | | 197.0 | | | (89.9) | | | 9.1 |
| Cash and debt for equity exchange transactions: | | | | | | | | | | | | | | | |
| 5.75% Senior Subordinated Notes due 2025 | | | 8.6 | | | 447,829 | | | 8.4 | | | (0.2) | | | 0.1 |
| 5.875% Senior Subordinated Notes due 2026 | | | 9.6 | | | 432,777 | | | 8.1 | | | (1.3) | | | 0.2 |
| Second Lien Notes due 2026 | | | 45.0 | | | 2,693,717 | | | 45.5 | | | (4.0) | | | 1.2 |
| Total cash and debt for equity exchange transactions | | | 63.2 | | | 3,574,323 | | | 62.0 | | | (5.5) | | | 1.5 |
| Total debt repurchases and exchanges | | $ | 382.9 | | | 47,654,455 | | $ | 318.1 | | $ | (100.1) | | $ | 12.1 |
44
Table of Contents
Vendor Dispute. On January 26, 2024, we executed an agreement to collect $37.5 million as resolution of a dispute with a vendor. The proceeds, net of legal costs, were recorded to other income during the year ended December 31, 2024. The relationship with the vendor has been restored and remains in good standing.
Share Issuances. During the year ended December 31, 2024, we raised gross proceeds of $261.8 million and paid fees to sales agents and incurred other third-party issuance costs of approximately $6.4 million and $1.9 million, respectively, through our at-the-market offerings of approximately 75.5 million shares of our Common Stock. We paid $0.8 million of other third-party issuance costs during the year ended December 31, 2024.
Additionally, we entered into forward transactions to sell 30.0 million shares of our Common Stock. During December 2024, we were paid $0.01 per share for the par value of the forward shares totaling $0.3 million. See Note 8—Stockholder’s Deficit in the Notes to the Consolidated Financial Statements under Part II, Item 8 of this Form 10-K for further information.
2024 Refinancing Transactions. During the year ended December 31, 2024, we completed a series of transactions to refinance $1,895.0 million aggregate principal amount of our senior secured term loans maturing in 2026 (“Term Loans due 2026”) and $518.6 million of our Second Lien Notes. As part of the transactions, we issued $2,024.3 million aggregate principal amount of the New Term Loans (as defined herein) and $414.4 million aggregate principal of Existing Exchangeable Notes. The repurchases of the Second Lien Notes were accounted for as extinguishments and resulted in a loss on extinguishment of $61.2 million. See the Liquidity and Capital Resources section below and Note 7—Corporate Borrowings and Finance Lease Liabilities in the Notes to the Consolidated Financial Statements under Part II, Item 8 of this Form 10-K for further information on these transactions.
Special Awards. On February 22, 2024, the compensation committee of AMC’s Board approved modification of the performance goals applicable to all 2023 Tranche Year PSU awards. This was accounted for as a modification to the 2023 Tranche Year PSU awards which lowered the Adjusted EBITDA and free cash flow performance targets such that 200% vesting was achieved for both targets. This modification resulted in the immediate additional vesting of 478,055 2023 Tranche Year PSUs (21,829 cash settled units and 456,226 equity settled units). This was treated as a Type 3 modification (improbable-to-probable) which required the Company to recognize additional stock compensation expense based on the modification date fair values of the incremental PSUs. During the year ended December 31, 2024, the Company recognized $2.1 million of stock compensation expense related to these awards.
Significant Events—For the Year Ended December 31, 2023
For a discussion of significant events for the year ended December 31, 2023, see “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our annual report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 28, 2024, which is incorporated herein by reference.
Critical Accounting Estimates
Our consolidated financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). In connection with the preparation of our financial statements, we are required to make a
[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]
MD&A history
Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.